{
    "clinical_study": {
        "@rank": "134364", 
        "arm_group": [
            {
                "arm_group_label": "Ribose", 
                "arm_group_type": "Experimental", 
                "description": "After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink."
            }
        ], 
        "brief_summary": {
            "textblock": "Investigate the acute effect of ribose supplementation on performance and recovery in\n      athletes."
        }, 
        "brief_title": "Ribose and Sport Performance", 
        "condition": "Sports", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women\n\n          -  Training volume > 7hrs/week\n\n          -  VO2 max  > 40 and 45 mg/kg/min (for women and men respectively)\n\n          -  Otherwise healthy individuals\n\n        Exclusion Criteria:\n\n          -  Pregnant or breastfeeding women\n\n          -  Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases,\n             gut diseases, cancer, anemia, hypoglycemia\n\n          -  Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases,\n             mood disorders\n\n          -  Excessive alcohol consumption (more than two drinks by day for men, one for women),\n             smoking, drug use, supplements or natural products consumption during the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01727479", 
            "org_study_id": "2012-048", 
            "secondary_id": "INAF-2012-048"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ribose", 
                "description": "After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.", 
                "intervention_name": "Ribose", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Peak VO2 consumption", 
            "3km time trial", 
            "fatigue perception", 
            "lactate", 
            "time to complete"
        ], 
        "lastchanged_date": "November 24, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1V0A6"
                }, 
                "name": "Universit\u00e9 Laval"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Ribose on Performance and Recovery in Athletes", 
        "other_outcome": [
            {
                "description": "Post-exercise fatigue perception on visual analog scale (VAS)", 
                "measure": "Fatigue perception after each of the 3 consecutive 3km time trials on bike", 
                "safety_issue": "No", 
                "time_frame": "baseline and 1 week"
            }, 
            {
                "measure": "Peak Vo2 consumption during each of the 3km time trials on bike", 
                "safety_issue": "No", 
                "time_frame": "baseline and 1 week"
            }
        ], 
        "overall_official": {
            "affiliation": "Institute on nutraceuticals and functional foods", 
            "last_name": "Beno\u00eet Lamarche, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in time to complete the third of 3 consecutive 3km time trials on bike", 
            "safety_issue": "No", 
            "time_frame": "baseline and 1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01727479"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)", 
            "measure": "Performance on the 3 consecutive 3km time trials on bike", 
            "safety_issue": "No", 
            "time_frame": "baseline and 1 week"
        }, 
        "source": "Laval University", 
        "sponsors": {
            "collaborator": {
                "agency": "Atrium Innovations", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Laval University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}